Cannabidiol (CBD) has recently gained a lot of attention for its potential to provide mental and physical health benefits. CBD is an essential component of medical marijuana, but it can also be derived directly from the hemp plant or manufactured in a laboratory. To better understand the therapeutic potential of CBD, we have compiled reliable research and conducted a survey on its prevalence and potential health benefits. The survey results showed that Americans aged 18 to 29 are more likely to consume CBD on a regular basis, and their popularity decreases with age. Of the respondents, those who used it for medical purposes were more likely to learn about CBD from a doctor or naturopathic doctor and to use it more frequently than those who used it for general health and well-being.
A large percentage of respondents reported that CBD effectively treats their condition(s) without conventional medications and with minimal adverse effects. The Food and Drug Administration (FDA) does not recognize CBD as an ingredient in dietary supplements due to its status as an investigational drug. However, the agency has analyzed the chemical content of some cannabinoid compounds in products and found that many did not contain the levels of CBD they claimed. In the United States, until it is rescheduled, the Drug Enforcement Administration (DEA) considers CBD in marijuana to fall within the scope of the “marijuana extract rule.”These data provide compelling justification for further research into the therapeutic potential of CBD in treating chronic pain, anxiety, depression, sleep disorders, and other medical conditions.
